Evidence map›Paper›PMID 29717473›Full record

Trial reportDrug delivery and translational research2018

Comparison of quick recovery outcome of inhalable doxorubicin and cisplatin in lung cancer patients: a randomized, double-blind, single-center trial.

Zhen Li, Min Song, Zhun He, Ling Zong, Bo Jiang, Tao Zhang, Zhiliang Hu

Abstract readComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Drug delivery and translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Inhaled Cisplatin for NSCLC: Facts and Results.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zhen LiDepartment of Thoracic Surgery, Jining Medical College Affiliated Hospital, No. 77 Gukui Street, Jining, 272000, Shandong, China.
Min SongDepartment of Endocrinology, Jining Medical College Affiliated Hospital, Jining, 272000, China.
Zhun HeDepartment of Thoracic Surgery, Jining Medical College Affiliated Hospital, No. 77 Gukui Street, Jining, 272000, Shandong, China.
Ling ZongDepartment of Thoracic Surgery, Jining Medical College Affiliated Hospital, No. 77 Gukui Street, Jining, 272000, Shandong, China.
Bo JiangDepartment of Thoracic Surgery, Jining Medical College Affiliated Hospital, No. 77 Gukui Street, Jining, 272000, Shandong, China.
Tao ZhangDepartment of Thoracic Surgery, Jining Medical College Affiliated Hospital, No. 77 Gukui Street, Jining, 272000, Shandong, China.
Zhiliang HuDepartment of Thoracic Surgery, Jining Medical College Affiliated Hospital, No. 77 Gukui Street, Jining, 272000, Shandong, China. HartnessApirt@yahoo.com.ORCID http://orcid.org/0000-0001-5243-5872
Affiliated Hospital of Jining Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systematic chemotherapy has required high time span for recovery in cancer patients, serious toxic effects, and increased the time of cancer-free survival of patient but decreased the overall survival time of patients irrespective of diseased condition(s). To compare the quick recovery of inhalable doxorubicin and cisplatin in the lung cancer patients. A total of 240 patients with non-small cell lung cancer (NSCLC) patients were randomly divided into two groups of 120 each. Patients had inhaled 25 mg/m TRIAL REGISTRY: researchregistry3382, dated 28 December 2014 ( www.researchregistry.com ).

Indexed as

Administration, InhalationAdultAgedCarcinoma, Non-Small-Cell LungCisplatinDouble-Blind MethodDoxorubicinDrug Administration ScheduleFemaleHumansLung NeoplasmsMaleMiddle AgedTreatment OutcomeCisplatinDoxorubicinCancerClinical pharmacologyClinical toxicologyDoxorubicinDrug deliveryHematologyInhaled chemotherapyMucositisOncologyRadiology

Identifiers

PMID29717473
OpenAlexW2801334787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.